(TSX:TFII),(NYSE:TFII), MONTREAL, Jan. 23, 2025 (GLOBE NEWSWIRE) — TFI International Inc. (NYSE and TSX: TFII), a North American leader in the transportation and logistics industry, today announced that it will release its financial results for the fourth quarter ended December 31, 2024 via news release on Wednesday, February 19, 2025 after market close. The company […]
The talk show host opens up about staying positive, her current attitude on dating, and growing up in front of the cameras. After decades of being in the spotlight, DrewBarrymore couldn't be happier about where her long-lasting career has taken her in life. In the February/March 2025 issue ofAARP The Magazine (ATM), the actor-turned-talk show
Saul Centers, Inc. (NYSE: BFS),anequityrealestate investmenttrust(REIT), announced today the income tax treatment of its 2024 dividends. During 2024, the Company declared and paid four quarterly dividends on its Common Stock totaling $2.36 per common share. For tax purposes, 71.66% of the dividends ($1.69 per common share) are characterized as ordinary income and 28.34% of the
NEW YORK, NY / ACCESSWIRE / January 23, 2025 / If you suffered a loss on your MGP Ingredients, Inc. (NASDAQ:MGPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/mgp-ingredients-inc-lawsuit-submission-form?prid=124636&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
LOS ANGELES, CA / ACCESS Newswire / January 23, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Match Group, Inc. ("Match" or "the Company") (NASDAQ:MTCH) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder
LOS ANGELES, CA / ACCESS Newswire / January 23, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated
NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124645&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Revance Therapeutics, Inc. (NASDAQ:RVNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/revance-therapeutics-inc-lawsuit-submission-form?prid=124633&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / January 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Johnson & Johnson ("Johnson & Johnson") (NYSE:JNJ) concerning possible violations of federal securities laws. J&J issued a press release on January 8, 2025, announcing that "on January 5, out of an abundance
NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Rentokil Initial plc (NYSE:RTO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rentokil-initial-plc-lawsuit-submission-form?prid=124627&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or